BioOrbit

Builds autonomous units that crystallise biologic cancer drugs in microgravity to enable injectable versions.

Why it's here

Raised a £9.8M seed co-led by LocalGlobe and Breega in May 2026, with Seedcamp and Auxxo participating.

Focus: In-Space Manufacturing
Founded: 2023
Latest round: Seed, £9.8M, May 2026
Staff (Companies House accounts): 7, average over the period to 31 Jul 2025source: find-and-update.company-information.service.gov.uk
London office: Busworks, Office 404, 39-41 North Road, Islington N7 9DPsource: bioorbit.com
London presence: HQsource: bioorbit.com
Investors: Breega (lead), LocalGlobe (lead), 7percent Ventures, Auxxo, Seedcamp, Type One Venturessource: payloadspace.com
Recognised on: Tech Nation Future Fifty 2025source: technation.io
Area: Elsewhere in London
Nearest station: Caledonian Road, 129 m
Companies House: BIOORBIT LTD (15035829, active)Incorporated 28 Jul 2023 · SIC 72110

For BioOrbit